IPR
Topic 102 Intro Intersections
Topic 102 — Introduction to IP Intersections
IP rights do not exist in isolation. They intersect with — and sometimes collide with — other legal frameworks: competition law (where exclusive rights conflict with anti-monopoly principles), constitutional law (right to occupation under Article 19(1)(g), right to health under Article 21, freedom of speech), public health (access to medicines vs. patent monopolies), data protection (DPDP Act 2023), human rights (TRIPS flexibilities), labour law (employee inventions, employee mobility), tax law (transfer pricing, royalty taxation), and international trade (TRIPS, bilateral FTAs). These intersections are sites of dynamic legal evolution — courts and regulators continuously rebalance competing values. The Indian framework demonstrates this through landmark cases: Novartis AG v. Union of India (SC 2013) — Section 3(d) anti-evergreening upheld over TRIPS challenge; Bayer v. Natco (Patent Office 2012) — India's first and only compulsory licence under Section 84 for affordability of cancer drug Nexavar; Telefonaktiebolaget v. CCI (Del HC 2016, SC SLP 2024 pending) — IP rights vs. competition law jurisdiction; Monsanto Holdings v. CCI (Del HC 2020) — Bt cotton trait fees as abuse of dominance; Shreya Singhal v. UoI (SC 2015) — IT Act 79 and free speech vs. IP enforcement online. The Competition Commission of India (CCI) operates Section 3(5) IP exception "reasonable conditions" framework. The Mediation Act 2023, DPDP Act 2023 (effective stages 2024-25), Competition (Amendment) Act 2023 (March 2024 settlement/commitment mechanisms; ₹2,000 crore deal value threshold; 2025 Penalty Guidelines), Cinematograph (Amendment) Act 2023, and Bharatiya Nyaya Sanhita 2023 (effective 1 July 2024) collectively reshape this landscape. This module opener walks through every IP intersection — competition law (Topic 103), constitutional law (Topic 104), data privacy (Topic 105), labour and employment (Topic 106), taxation (Topic 107), and intersections compendium (Topic 108).
1. The Six Major IP Intersections
1 COMPETITION CCI + Section 3(5) | 2 CONSTITUTIONAL Articles 14, 19, 21 | 3 DATA PRIVACY DPDP Act 2023 |
4 LABOUR LAW employee inventions | 5 TAXATION royalty + transfer pricing | 6 INTERNATIONAL TRIPS + FTAs |
2. Why Intersections Matter
A. Competing Values in IP
✅ The fundamental tension in IP law IP grants exclusive rights — but exclusive rights inherently restrict: · Competition (other producers excluded). · Free speech (creative re-use restricted). · Health access (patented drugs unaffordable). · Privacy (IP enforcement may invade personal data). · Employment (employees restrained from using prior knowledge). · International trade (national IP differences create barriers). The RESOLUTION is rarely absolute — instead, REASONABLE BALANCING: · Competition law: Section 3(5) "reasonable conditions" exception. · Constitutional law: Article 19(2) reasonable restrictions on Article 19(1)(g); Article 21 right to health balanced with patent monopolies. · Public health: TRIPS flexibilities (Section 3(d), Section 84 compulsory licensing). · Privacy: DPDP Act 2023 lawful basis framework. · Labour: Employer inventions vs. employee freedom. · Trade: National flexibility within TRIPS framework. This balancing is the work of courts, regulators, legislatures, and international institutions. |
B. Sources of Legal Conflict
Conflict | IP Side | Other Side |
|---|---|---|
IP vs Competition | Section 3(5) exemption for reasonable conditions. | Section 4 abuse of dominance (no exception for IP). |
IP vs Constitution | Patent/copyright monopolies. | Article 19(1)(g) right to occupation; Article 21 right to health. |
IP vs Privacy | IP enforcement requires identification. | DPDP Act 2023 personal data protection. |
IP vs Labour | Employer ownership of inventions. | Employee freedom; non-compete restrictions. |
IP vs International Trade | National IP regimes. | TRIPS minimum standards. |
IP vs Free Speech | Copyright restrictions. | Article 19(1)(a) freedom of expression; Section 52 fair dealing. |
IP vs Public Interest | Brand exclusivity. | Generic competition; access to essential goods. |
3. The Resolution Frameworks
A. Constitutional Framework
- Article 14 — equality before law (challenged Section 3(d) Patents Act).
- Article 19(1)(a) — freedom of speech (vs. copyright restrictions).
- Article 19(1)(g) — right to occupation (vs. IP barriers to entry).
- Article 19(2) — reasonable restrictions framework.
- Article 21 — right to life and health (vs. patent monopolies on medicines).
- Article 31 — repealed (1978); right to property no longer fundamental.
B. Statutory Resolution Mechanisms
Mechanism | Statute | Purpose |
|---|---|---|
Section 3(5) Competition Act | Competition Act 2002 | IP "reasonable conditions" exception. |
Section 3(d) Patents Act | Patents Act 1970 (1 January 2005 amendment) | Anti-evergreening (only NEW efficacy patentable). |
Section 84 Patents Act | Patents Act 1970 | Compulsory licensing on grounds (not worked, unaffordability, public need). |
Section 92 Patents Act | Patents Act 1970 | Government use compulsory licensing for public emergency. |
Section 100 Patents Act | Patents Act 1970 | Government use without licence (rarely invoked). |
Section 52 Copyright Act | Copyright Act 1957 | Fair dealing exceptions. |
Section 79 IT Act | IT Act 2000 | Intermediary safe harbour balancing IP enforcement with free expression. |
Section 19 DPDP Act | DPDP Act 2023 | Lawful basis for processing personal data; intersects with IP enforcement requiring identification. |
C. International Framework
- TRIPS Agreement — minimum IP standards.
- Doha Declaration 2001 — TRIPS flexibilities for public health.
- TRIPS Article 8 — public interest principles.
- TRIPS Article 31 — compulsory licensing framework.
- TRIPS Article 30 — limited exceptions to patent rights.
- TRIPS Article 27.2 — public order exception (ordre public).
- Bilateral Investment Treaties — IP protection.
- FTAs (e.g., India-EU, RCEP) — TRIPS-Plus provisions.
4. Indian Landmark Intersection Cases — Overview
Case | Intersection | Outcome |
|---|---|---|
Novartis v. UoI (SC 2013) | IP + Public Health + TRIPS | Section 3(d) upheld; anti-evergreening prevails. |
Bayer v. Natco (PO 2012) | IP + Public Health + Constitutional | India's only compulsory licence; Sorafenib accessible. |
Telefonaktiebolaget v. CCI (Del HC 2016) | IP + Competition Law | Patents Act prevails over Competition Act in patent disputes. |
Monsanto Holdings v. CCI (Del HC 2020) | IP + Competition Law | CCI has jurisdiction over IP-related abuse of dominance. |
CCI v. Ericsson + Monsanto (SC SLP 2024) | IP + Competition Law | Pending Supreme Court resolution. |
Telefonaktiebolaget v. Lava (Del HC 2024:DHC:2698) | IP + Competition + International | Substantial SEP damages; FRAND framework. |
Shreya Singhal v. UoI (SC 2015) | IP + Free Speech + Internet | Section 79 IT Act read down; "actual knowledge" requires court order. |
ANI Media v. OpenAI (Del HC 2024) | IP + Free Speech + AI | AI training fair dealing; judgment reserved 2025. |
5. The Three Approaches to Resolution
A. Internal Resolution (within IP statute)
- Section 3(d) — anti-evergreening within Patents Act.
- Section 84 — compulsory licensing within Patents Act.
- Section 52 — fair dealing within Copyright Act.
- Section 30 — exceptions within Trade Marks Act (research, educational use).
- Section 47 — research/private use exception within Patents Act.
B. External Resolution (other statute)
- Competition Act 2002 — Section 3(5) "reasonable conditions" + Section 4 abuse of dominance.
- DPDP Act 2023 — personal data protection.
- IT Act 2000 — intermediary safe harbour.
- Cinematograph (Amendment) Act 2023 — anti-piracy.
- Income Tax Act — royalty taxation.
C. Constitutional Resolution
- Public interest review — Article 14, 19, 21 challenges to IP law.
- Statutory interpretation aligned with Fundamental Rights.
- Judicial review of IP regulator decisions.
- Doctrine of pith and substance for inter-statutory conflicts.
6. Recent Trends and Reforms
✅ 2023-2025 IP Intersections Reforms 1. COMPETITION LAW REFORMS · Competition (Amendment) Act 2023 — major overhaul. · Settlement and Commitment mechanisms (March 2024). · Deal Value Threshold ₹2,000 crore for digital mergers. · Penalty Guidelines 2024 — global turnover basis. · Clause 4A proposed (IP exception expanded to Section 4). 2. DATA PROTECTION · DPDP Act 2023 — comprehensive personal data law. · Effective stages 2024-25. · Affects IP enforcement (data minimization, consent). 3. CRIMINAL LAW REFORMS · BNS 2023 effective 1 July 2024 (replaced IPC 1860). · BNSS 2023 effective 1 July 2024. · BSA 2023 effective 1 July 2024. · Affects IP criminal prosecution. 4. INTERMEDIARY FRAMEWORK · IT Rules 2021 modernized intermediary obligations. · Cinematograph (Amendment) Act 2023 anti-piracy provisions. · DPDP Act 2023 cross-references. 5. INSTITUTIONAL · IPAB abolition (2021) — IP appeals to High Courts. · HC IP Divisions (Delhi 2021; Madras April 2023; Calcutta; HP; Karnataka pending). · Mediation Act 2023. |
7. Strategic Considerations
✅ For IP rights holders — eight points For Standard Essential Patents, anticipate FRAND obligations and CCI scrutiny. For pharmaceutical patents, consider Section 3(d) compliance and Section 84 risk. For digital platform operations, integrate IP enforcement with DPDP Act compliance. For employment IP, draft non-disclosure and assignment agreements aligned with labour law. For international IP, assess TRIPS flexibilities and bilateral protection. For litigation strategy, consider parallel competition + IP claims. For licensing, draft "reasonable conditions" within Section 3(5) framework. For brand enforcement, balance rights protection with free speech considerations. |
✅ For competitors and challengers — six points For pharmaceutical access, leverage Section 3(d) and Section 84. For digital platform challenges, use Competition Act + IP framework. For employment mobility, leverage labour law protections. For research/educational use, leverage Section 52 fair dealing. For regulatory exclusivity challenges, use Section 3(d). For data protection, invoke DPDP Act 2023 protections. |
🎯 EXAM POINTERS — TOPIC 102
|